Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Senior research of the clinical biochemistry - drug delivery and therapy group at VHIR and Strategy director of biobanking and biomodels at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 48, with more that 120 high impact publications, 19 transferred patents and several EU granted projects. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM. Exper member of the nanomedicine group at EMA.
Projects Vías moleculares de respuesta genotóxica al tratamiento quimio- y radioterápico tumoral. Detección de nuevos implicados. IP: Simon Schwartz Navarro Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 1393.2 Reference: BF03/00595 Duration: 01/01/2004 - 30/11/2007 Inestabilitat genòmica i mitocondrial en càncer IP: Simon Schwartz Navarro Collaborators: Eloy Espín Basany Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 6010.12 Reference: 2001XT 00069 Duration: 05/02/2002 - 19/02/2004 Mutaciones somáticas mitocondriales en tumores gástricos y su asociación con el pronóstico tumoral. Dinámica mutacional de heteroplasmias en la línea colorectal inestable DLD-1. IP: Simon Schwartz Navarro Collaborators: José Manuel Pena Ezquerra, Jordi Giralt López de Sagred, Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Instituto de Salud Carlos III Funding: 112125 Reference: PI020295 Duration: 06/11/2002 - 06/11/2005 Aplicabilidad clinica del analisis de la inestabilidad de microsatelites en el cancer colorectal. diagnostico molecular del cancer colorectal hereditario no polipoide (hnpcc) y protocolos alternativos de diagnostico. IP: Simon Schwartz Navarro Collaborators: José Manuel Pena Ezquerra, Jordi Giralt López de Sagred, Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Instituto de Salud Carlos III Funding: 95861.43 Reference: 01/1350 Duration: 17/07/2001 - 31/12/2003 Pagination First page « Previous page ‹ … Page 7 Page 8 Page 9 Page 10 Current page 11
